... patients on day 2 of cycles 2, 4, and 6 as well as completion of treat-ment; for Arm B patients, on day 22 of cycle 1 and day 1 of cycles 2 and 3 and completion of treatment. In thecase of missing ... USA.7Department of Medicine, University of Wisconsin, Madison, WI, USA.Authors’ contributionsRSD, YC, MS, MC, BR, EW, and GW contributed to enrollment, conception,design, interpretation of data and reading ... 8:20http://www.translational-medicine.com/content/8/1/20Page 6 of 9studies demonstrating an effect of CRA/IFN on Bcl-2regulation [3-6]. We found a modest PSA response rate of 23% and a progression free survival of only 2.5months....